全球延長留置周邊導管市場：市場規模、佔有率和趨勢分析（2025-2032 年）

全球延長留置週邊導管市場報告（至2032年）

2025年全球延長留置週邊導管市場規模約6,800萬美元。預計該市場將以5.8%的複合年成長率成長，到2032年達到1億美元。

本報告涵蓋全球留置導管（EDC）市場，包括手術量、市場規模、銷售量和平均售價的區域趨勢。

分析內容包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要受導管相關併發症減少、首次穿刺成功率提高以及EDC作為PICC和中線導管低成本替代方案的推動。然而，競爭壓力、價格下降以及新型PIVC和中線導管技術的出現預計將抑制市場規模的進一步成長。

市場概覽

全球延長留置週邊導管市場包括旨在提供比傳統週邊靜脈導管更長留置時間的導管，為 PICC 和中線導管提供了更簡單且通常成本更低的替代方案。

EDC適用於需要長期週邊靜脈通路但不需要完全中心靜脈通路的患者。這使得EDC介於標準PIVC和長期血管通路方案（如中線導管或PICC）之間。

雖然價格因地區而異，但全球平均售價 (ASP) 相對穩定。北美地區的平均售價最高，這得益於其醫院預算充足以及對高階品牌的偏好。

在其他地區，隨著本地經銷商和區域製造商進入市場，價格壓力日益增加。在預測期內，平均售價預計將以約3%的複合年成長率逐步下降，部分抵銷銷售成長帶來的市場價值成長。

市場促進因素

減少導管相關併發症

減少導管相關併發症是推動EDC技術普及的主要動力。與傳統週邊靜脈置管相比，EDC可以減少再次置管的需要，並提高首次置管的成功率。

這些益處可以降低導管相關併發症和針刺傷的整體發生率。這些問題會為醫院帶來高昂的成本，並對病患體驗產生負面影響。

由於EDC（內分泌導管）具有降低導管再次插入風險的潛力，一些醫療專業人員認為，在某些情況下，EDC相比PIVC（外周靜脈留置針）更高的成本是合理的。預計這將加速EDC的普及，並使其能夠佔PIVC市場的部分需求。

PICC和中線置管的低成本替代方案

對於某些患者而言，EDC 也可作為 PICC 或中線導管的低成本替代方案。當需要較長的留置時間，或並非必須建立中心靜脈通路時，EDC 可作為實用的過渡選擇。

這種定位至關重要，因為醫療專業人員需要不斷權衡導管性能、併發症風險、插入難度和成本。 EDC 可以滿足臨床需求，而無需像某些長期留置裝置那樣承擔高昂的成本和複雜的插入流程。

這一價值提案支持在醫院和替代醫學機構中採用 EDC，因為臨床醫生需要長期使用，但不希望立即過渡到 PICC 或中線護理。

改進插入技術

新型器械設計正在增強臨床醫生的信心，並促進電子設備傳輸系統（EDC）的普及。例如，BD公司的AccuCath® Ace整合了導管導引線技術，旨在提高置管成功率。

提高插管表現至關重要，因為首次插管的成功與否直接影響病人的舒適度和臨床工作流程。簡化插管操作的設備可以減輕訓練負擔、節省時間，並使內分泌採集系統（EDC）更加實用和通用，適用於更廣泛的應用情境。

隨著製造商不斷改進植入技術和設備設計，預計內分泌干擾物（EDC）的使用率將會增加。鑑於泰利福（Teleflex）召回事件後，醫院和臨床醫生正在重新評估可用的長期植入方案，這一趨勢在當下尤其重要。

市場限制

競爭壓力

競爭壓力是EDC市場的主要限制。由於EDC與週邊靜脈導管（PIVC）和中線導管有相似之處，因此這些大規模血管通路領域的主要競爭對手可能會進入EDC市場。

隨著更多大型製造商進入市場，價格競爭可能會加劇。現有的電子資料收集（EDC）競爭對手可能會降低價格以保住市場佔有率，尤其是在醫院對成本較為敏感的地區。

這可能導致平均售價下降，從而限制市場價值的成長。即使銷售量增加，降價也可能抵消部分因產品普及而帶來的收入成長。

新型PIVC與中線技術

新型週邊靜脈置管（PIVC）和中線置管技術也將成為外用輸液器（EDC）市場的限制因素。 PIVC市場安全性的提高有望降低併發症發生率，從而可能減少對高價EDC的需求。

如果週邊靜脈留置針（PIVC）變得更安全、更穩定、更容易固定，一些醫療機構可能會選擇繼續使用PIVC，而不是改用外用輸液港（EDC）。對於不需要長期留置的患者來說，尤其如此。

中線器材也與EDC（內分泌設備）有競爭關係。像Teleflex和Spectrum Vascular這樣的公司生產的產品具有抗菌和抗血栓等特性。這些特性在EDC市場尚未普及，這可能會導致一些醫療機構對EDC的興趣降低。

平均售價（ASP）略有下降

市場也受到平均售價預期下降的限制。儘管預計銷量將會增加，但全球平均售價預計在預測期內將略有下降。

儘管預計北美地區的平均售價將維持在高位，但其他許多地區則面臨來自區域製造商和當地分銷商的壓力。這些供應商在價格方面可能會更具競爭力。

價格上漲趨勢將抵銷銷售成長帶來的部分價值提升。因此，儘管市場擴張穩步推進，但預計其強勁程度將不如僅根據銷售趨勢所預測的那樣。

市場範圍和數據範圍

• 量化研究範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數、平均售價。
• 定性研究範圍：市場促進因素和阻礙因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
• 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
• 建立市場模型：收入分析採用銷售量和平均售價（ASP），並輔以治療量、競爭市場佔有率分析和預測假設。
• 目標設備：本報告重點關注延長留置週邊導管，包括區域手術趨勢、市場規模、銷售量和平均售價 (ASP)。

目標市場及區隔

延長留置週邊導管市場

本報告涵蓋了全球延長留置週邊導管市場，作為專用靜脈通路裝置的細分市場。

延長留置週邊導管的設計目的是提供比傳統週邊靜脈導管（PIVC）更長的通路時間。當患者需要長期週邊通路但不需要PICC、中線或中央靜脈導管時，通常會使用延長留置週邊導管。

此市場分析依據市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價。

本報告根據併發症減少、首次穿刺成功率、定價趨勢、競爭格局、產品召回、臨床醫生信心以及來自 PIVC 和中線選擇的競爭來評估需求。

這種配置有助於製造商、投資者和策略團隊了解 EDC 在更廣泛的血管通路市場中的定位，以及它如何作為短期 PIVC 和長期通路裝置之間的實用替代方案來獲得市場佔有率。

競爭分析

2025年，由於泰利福（Teleflex）公司召回其Arrow® Endurance™產品，全球延長留置週邊導管市場經歷了重大的結構性變化。雖然召回行動最初在美國啟動，但泰利福公司向其經銷商發出的關於美國以外地區銷售和強制性產品召回的指示，實際上導致該產品在多個地區被撤出市場。

這次事件徹底改變了競爭格局。貝克頓·迪金森公司從召回事件引發的市場變化中獲益匪淺，並一躍成為世界領先的EDC（電子物品攜帶設備）供應商之一。

BD的EDC產品系列包括AccuCath®和AccuCath® Ace，這兩款產品均支援長達29天的留置時間。除了旗艦產品5.7公分的AccuCath® Ace之外，更短、更經濟實惠且類似於傳統參與企業留置針的裝置也助力BD在EDC領域佔了主導地位。

預計到 2025 年，ICU Medical 將成為全球 EDC 市場第二大公司。 2022 年收購 Smiths Medical 後，其市場地位已鞏固，而 Smiths Medical 先前已透過 Access Scientific 進入該市場。

ICU Medical 的旗艦產品 Powerwand™ EDC 是一款採用 ChronoFlex 材料和 BioGUARD™ 技術的電動注射導管。與改良的 Seldinger 技術相比，該設備旨在簡化插入過程。與 BD 一樣，在 Teleflex 召回事件後，ICU Medical 的市佔率也有所成長。

2025年，Vygon在電子輸液設備（EDC）市場迅速崛起。其旗艦產品Leaderflex®是市面上唯一非電動輸液裝置，最長留置時間可達29天。 Leaderflex提供多種長度選擇，包括6公分的短款，吸引了許多尋求可靠長期留置方案的醫院的注意。

科技與醫療治療的發展趨勢

長期住院治療

對於需要長期週邊靜脈通路且標準週邊靜脈導管 (PIVC) 不足以滿足需求的患者而言，長期留置通路變得越來越重要。

EDC有助於彌合短期PIVC與長期選擇（如中線導管和PICC）之間的差距。

首次穿刺成功率

提高首次穿刺成功率是EDC的一項主要臨床優勢。減少穿刺次數可以減輕病患不適，節省醫護人員時間，並降低針刺傷的風險。

這將有助於為血管通路受限的患者引入這種治療方法。

一體化導管導引線設計

整合導管導引線技術有助於提高插入的可靠性。 BD 的 AccuCath® Ace 就是一個旨在提高植入性能並簡化工作流程的器械範例。

這些特點使 EDC 能夠與傳統的 PIVC 區分開來。

可注入式EDC

可注射式增強造影劑為需要造影增強影像的患者提供了更大的柔軟性。 ICU Medical 的 Powerwand™ 就是此類產品的代表。

能量注入功能使得產品價格更高，臨床應用範圍更廣。

召回事件引發的市場重組

Teleflex公司召回Arrow® Endurance™產品改變了市場競爭格局。醫院和臨床醫生開始尋找替代的電子輸液器，這促使BD、ICU Medical和Vygon等公司的市場佔有率增加。

預計這項變更將在預測期內對購買模式產生影響。

來自當地供應商的價格壓力

區域性製造商和經銷商正陸續進入EDC市場，尤其是在北美以外的地區。預計這將加劇價格壓力，並導致平均售價（ASP）略有下降。

供應商將被迫在可靠性、插入成功率、產品設計和成本方面競爭。

地區

本報告涵蓋全球調查區域，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

• 目前全球延長留置週邊導管的市場規模有多大？預計到 2032 年將成長多少？
• 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
• EDC 在 PIVC、中線導管和 PICC 之間處於什麼位置？
• 為什麼EDC作為PICC和中線導管系統的低成本替代方案越來越受歡迎？
• EDC 如何減少重複插入、併發症和針刺傷？
• Teleflex召回Arrow® Endurance™對競爭格局產生了怎樣的影響？
• BD、ICU Medical 和 Vygon 在 EDC 市場中處於什麼位置？
• 為什麼本地製造商和經銷商會施加價格壓力？
• 平均售價（ASP）逐漸下降會對市場價值成長產生什麼影響？
• 導管導引線整合和電注入設計等哪些技術趨勢正在推動電子資料擷取 (EDC) 的廣泛應用？

iData Research 的「全球延長留置週邊導管市場報告」透過設備層級分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、與競爭對手進行基準比較、了解召回造成的市場變化，並協助您制定全球延長留置週邊導管市場的產業計畫。

目錄

調查方法

• 步驟 1：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 步驟 4：進行初步調查
• 步驟 5：調查與分析：建立基準估計值
• 步驟 6：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟 9：客戶回饋與市場監測

全球關稅的影響

延長留置週邊導管市場

• 摘要整理
  • 全球延長留置週邊導管市場概覽
  • 競爭分析
  • 目標區域
• 介紹
• 手術次數
  • 置入術的整體流程
• 市場分析與預測
  • 整體長期住宿市場
• 促進因素和抑制因素
• 競爭性市佔率分析

簡稱

Global Extended Dwell Catheter Market Report to 2032

The global extended dwell catheter market was valued at around $68 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.8%, reaching $100 million by 2032.

This report covers the global market for extended dwell catheters (EDCs), including regional procedure volumes, market values, unit sales, and average selling price trends.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by reduced catheter-related complications, improved first-stick success, and the use of EDCs as a lower-cost alternative to PICCs and midlines. However, competitive pressure, pricing erosion, and new PIVC and midline technologies are expected to limit stronger market value growth.

Market Overview

The global extended dwell catheter market includes catheters designed to provide longer dwell times than traditional peripheral intravenous catheters, while offering a less complex and often lower-cost alternative to PICCs and midlines.

EDCs are used for patients who require extended peripheral access but may not require full central venous access. This positions them between standard PIVCs and longer-term vascular access options such as midlines and PICCs.

ASPs remain relatively stable at the global level, although pricing conditions vary by region. North America maintains the highest ASPs due to stronger hospital budgets and preference for premium branded devices.

In other regions, pricing pressure is increasing as local distributors and regional manufacturers enter the market. Over the forecast period, ASPs are expected to decline modestly at a CAGR of around 3%, offsetting some of the market value gains created by rising unit sales.

Market Drivers

Reduced Rate of Catheter-Related Complications

Reduced catheter-related complications are a major driver of EDC adoption. Compared with traditional PIVCs, EDCs can reduce the need for additional catheter insertions and increase the rate of first-stick success.

These benefits can lower the overall rate of catheter-related complications and needlestick injuries. Both issues can be costly for hospitals and can negatively affect patient experience.

Because EDCs may reduce repeat insertions, some healthcare providers view their higher cost compared with PIVCs as justifiable in selected cases. This is expected to support EDC adoption and allow EDCs to cannibalize some demand from the PIVC market.

Lower-Cost Alternative to PICCs and Midlines

EDCs are also positioned as a lower-cost alternative to PICCs and midlines in selected patients. When longer dwell time is needed but central access is not required, EDCs can offer a practical middle-ground option.

This positioning is important because healthcare providers are often balancing catheter performance, complication risk, insertion complexity, and cost. EDCs can meet a clinical need without requiring the higher cost or more involved placement workflow associated with some longer-term access devices.

This value proposition supports EDC growth in hospitals and alternate care settings where clinicians want extended access but do not want to escalate immediately to a PICC or midline.

Improved Insertion Technology

New device designs are improving clinician confidence and supporting EDC uptake. BD's AccuCath(R) Ace, for example, includes integrated guidewire technology and is designed to improve insertion success.

Improved insertion performance is important because first-stick success can affect both patient comfort and clinical workflow. Devices that simplify insertion can reduce training burden, save time, and make EDCs more practical for broader use.

As manufacturers continue improving insertion technology and device design, EDC adoption is expected to increase. This trend is especially important following the Teleflex recall, as hospitals and clinicians reassess available extended dwell options.

Market Limiters

Competitive Pressures

Competitive pressure is a key limiter in the EDC market. Because EDCs share similarities with both PIVCs and midlines, major competitors from those larger vascular access segments could enter the EDC space.

If more large manufacturers enter the market, pricing competition could intensify. Existing EDC competitors may reduce prices to defend market share, especially in regions where hospitals are highly cost-sensitive.

This could drive ASPs downward and limit market value growth. Even if unit sales increase, price erosion may offset some of the revenue gains from broader adoption.

New PIVC and Midline Technologies

New PIVC and midline technologies also limit the EDC market. Improved safety features in the PIVC market are expected to reduce complication rates, which could reduce the need for premium-priced EDCs.

If PIVCs become safer, more stable, and easier to secure, some providers may choose to continue using PIVCs rather than switch to EDCs. This is especially relevant for patients who do not require a long dwell time.

Midlines also compete with EDCs. Products from companies such as Teleflex and Spectrum Vascular offer antimicrobial and antithrombogenic properties. These features have not yet penetrated the EDC market to the same extent, which may reduce interest in EDCs among some healthcare providers.

Modest ASP Decline

The market is also limited by expected ASP decline. While unit sales are forecast to rise, global ASPs are expected to decline modestly over the forecast period.

North America is expected to maintain higher ASPs, but many other regions are facing pressure from regional manufacturers and local distributors. These suppliers can compete aggressively on price.

This pricing trend will offset some of the value gains created by unit growth. As a result, market expansion is expected to remain steady but not as strong as the unit sales trajectory alone would suggest.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers extended dwell catheters, including regional procedure volumes, market values, unit sales, and ASP trends.

Markets Covered and Segmentation

Extended Dwell Catheter Market

The report covers the global extended dwell catheter market as a dedicated vascular access device segment.

Extended dwell catheters are designed to provide longer access duration than traditional PIVCs. They are often used when patients require extended peripheral access but may not need a PICC, midline, or central venous catheter.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

The report evaluates demand based on complication reduction, first-stick success, pricing trends, competitive dynamics, product recalls, clinician confidence, and competition from PIVCs and midlines.

This structure helps manufacturers, investors, and strategy teams understand how EDCs are positioned within the broader vascular access market and how they may gain share as a practical alternative between short-term PIVCs and longer-term access devices.

Competitive Analysis

In 2025, the global extended dwell catheter market underwent a notable structural shift following the recall of Teleflex's Arrow(R) Endurance(TM) device. Although the recall was formally initiated in the United States, Teleflex's guidance to distributors regarding non-U.S. distribution and mandatory product return effectively resulted in withdrawal across multiple regions.

This disruption reshaped the competitive landscape. Becton Dickinson emerged as the leading global EDC supplier, benefiting significantly from the recall-driven market shift.

BD's EDC portfolio includes AccuCath(R) and AccuCath(R) Ace, both rated for dwell times of up to 29 days. The company's flagship 5.7 cm AccuCath(R) Ace, along with shorter and more cost-effective devices that resemble conventional PIVCs, positioned BD as the dominant player in the EDC segment.

ICU Medical ranked second in the global EDC market in 2025. Its position was strengthened by the 2022 acquisition of Smiths Medical, which had previously entered the market through Access Scientific.

ICU Medical's key offering, the Powerwand(TM) EDC, is a power-injectable catheter made from ChronoFlex material with BioGUARD(TM) technology. The device is designed to simplify insertion compared with the modified Seldinger technique. Like BD, ICU Medical expanded share following the Teleflex recall.

Vygon was a growing competitor in the EDC space in 2025. Its main product, Leaderflex(R), provides dwell times up to 29 days and stands out as the only non-power-injectable device on the market. Offered in multiple lengths, including a shorter 6 cm option, Leaderflex gained attention as hospitals searched for reliable extended dwell alternatives.

Technology and Practice Trends

Extended Dwell Access

Extended dwell access is becoming more important for patients who need longer peripheral access than a standard PIVC can provide.

EDCs help fill the gap between short-term PIVCs and longer-term options such as midlines or PICCs.

First-Stick Success

Improved first-stick success is a major clinical advantage for EDCs. Fewer insertion attempts can reduce patient discomfort, save staff time, and lower the risk of needlestick injury.

This supports adoption in patients with difficult vascular access.

Integrated Guidewire Designs

Integrated guidewire technology is helping improve insertion confidence. BD's AccuCath(R) Ace is an example of a device designed to improve placement performance and simplify workflow.

These features can help differentiate EDCs from conventional PIVCs.

Power-Injectable EDCs

Power-injectable EDCs provide additional flexibility for patients who may require contrast-enhanced imaging. ICU Medical's Powerwand(TM) is one example of this category.

Power capability can support premium pricing and broader clinical use.

Recall-Driven Market Realignment

The Teleflex Arrow(R) Endurance(TM) recall reshaped the competitive environment. Hospitals and clinicians looked for alternative EDC options, creating share gains for BD, ICU Medical, and Vygon.

This shift is expected to influence purchasing patterns over the forecast period.

Pricing Pressure from Regional Suppliers

Regional manufacturers and distributors are entering the EDC space, especially outside North America. This is expected to create pricing pressure and modest ASP decline.

Suppliers will need to compete on reliability, insertion success, product design, and cost.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global extended dwell catheter market today, and how much is it expected to grow through 2032?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• How are EDCs positioned between PIVCs, midlines, and PICCs?
• Why are EDCs gaining adoption as a lower-cost alternative to PICCs and midlines?
• How do EDCs reduce repeat insertions, complications, and needlestick injuries?
• What impact did the Teleflex Arrow(R) Endurance(TM) recall have on the competitive landscape?
• How are BD, ICU Medical, and Vygon positioned in the EDC market?
• Why are regional manufacturers and distributors creating pricing pressure?
• How will modest ASP decline affect market value growth?
• What technology trends are shaping EDC adoption, including guidewire integration and power-injectable designs?

The Global Extended Dwell Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand recall-driven market shifts, and support commercial planning in the global extended dwell catheter market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Extended Dwell Catheter Market

• 9.1 Executive Summary
  • 9.1.1 Global Extended Dwell Catheter Market Overview
  • 9.1.2 Competitive Analysis
  • 9.1.3 Regions Included
• 9.2 Introduction
• 9.3 Procedure Numbers
  • 9.3.1 Total Extended Dwell Catheter Procedures
• 9.4 Market Analysis And Forecast
  • 9.4.1 Total Extended Dwell Market
• 9.5 Drivers And Limiters
  • 9.5.1 Market Drivers
  • 9.5.2 Market Limiters
• 9.6 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 9-1: Extended Dwell Catheter Market, Global, 2025 & 2032
• Chart 9-2: Extended Dwell Catheter Market, Global, 2025
• Chart 9-3: Extended Dwell Catheter Procedures by Region, Global, 2022 - 2032
• Chart 9-4: Leading Competitors, Extended Dwell Catheter Market, Global, 2025

LIST OF FIGURES

• Figure 9-1: Extended Dwell Catheter Regions Covered, Global (1 of 2)
• Figure 9-2: Extended Dwell Catheter Regions Covered, Global (2 of 2)
• Figure 9-3: Extended Dwell Catheter Procedures by Region, Global, 2022 - 2032
• Figure 9-4: Extended Dwell Catheter Procedures by Country, North America, 2022 - 2032
• Figure 9-5: Extended Dwell Catheter Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 9-6: Extended Dwell Catheter Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 9-7: Extended Dwell Catheter Procedures by Country, Western Europe, 2022- 2032 (1 of 2)
• Figure 9-8: Extended Dwell Catheter Procedures by Country, Western Europe, 2022 - 2032 (2 of 2)
• Figure 9-9: Extended Dwell Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 9-10: Extended Dwell Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)

Figure 9 11 Extended Dwell Catheter Procedures by Country, Middle East, 2022 - 2032

• Figure 9-12: Extended Dwell Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 9-13: Extended Dwell Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 9-14: Extended Dwell Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 9-15: Extended Dwell Catheter Procedures by Country, Africa, 2022 - 2032
• Figure 9-16: Extended dwell catheter Market, Global, 2022 - 2032
• Figure 9-17: Units Sold by Region, Extended dwell catheter Market, Global, 2022 - 2032
• Figure 9-18: Average Selling Price by Region, Extended dwell catheter Market, Global, 2022 - 2032 (US$)
• Figure 9-19: Market Value by Region, Extended dwell catheter Market, Global, 2022 - 2032 (US$M)
• Figure 9-20: Leading Competitors, Extended Dwell Catheter Market, Global, 2025